Parkside Investments’s CME Group CME Stock Holding History

Parkside Investments’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Sell	5,493 -45	-0.8%	-$12.4K	0.13%	62
2026 Q1	$1.64M	Buy	5,538 +82	+2%	+$24.4K	0.2%	55
2025 Q4	$1.49M	Buy	5,456 +6	+0.1%	+$1.63K	0.19%	60
2025 Q3	$1.47M	Buy	5,450 +5	+0.1%	+$1.36K	0.18%	59
2025 Q2	$1.5M	Buy	5,445 +6	+0.1%	+$1.63K	0.2%	59
2025 Q1	$1.44M	Buy	5,439 +35	+0.6%	+$8.63K	0.21%	56
2024 Q4	$1.25M	Buy	5,404 +6	+0.1%	+$1.38K	0.19%	57
2024 Q3	$1.19M	Buy	5,398 +6	+0.1%	+$1.24K	0.18%	57
2024 Q2	$1.06M	Buy	5,392 +7	+0.1%	+$1.45K	0.17%	62
2024 Q1	$1.16M	Buy	5,385 +35	+0.7%	+$7.35K	0.18%	60
2023 Q4	$1.13M	Buy	5,350 +6	+0.1%	+$1.28K	0.19%	61
2023 Q3	$1.07M	Buy	5,344 +6	+0.1%	+$1.19K	0.2%	57
2023 Q2	$989K	Buy	5,338 +6	+0.1%	+$1.11K	0.18%	59
2023 Q1	$1.02M	Buy	5,332 +34	+0.6%	+$6.15K	0.19%	59
2022 Q4	$891K	Buy	5,298 +6	+0.1%	+$1.04K	0.18%	64
2022 Q3	$937K	Buy	5,292 +6	+0.1%	+$1.19K	0.2%	63
2022 Q2	$1.08M	Buy	5,286 +5	+0.1%	+$1.06K	0.23%	59
2022 Q1	$1.26M	Buy	5,281 +19	+0.4%	+$4.46K	0.25%	61
2021 Q4	$1.2M	Buy	5,262 +4	+0.1%	+$880	0.23%	60
2021 Q3	$1.02M	Buy	5,258 +5	+0.1%	+$1.01K	0.21%	64
2021 Q2	$1.12M	Buy	5,253 +4	+0.1%	+$845	0.21%	68
2021 Q1	$1.07M	Buy	5,249 +7	+0.1%	+$1.38K	0.22%	70
2020 Q4	$954K	Sell	5,242 -10,951	-68%	-$1.86M	0.21%	70
2020 Q3	$2.71M	Buy	16,193 +440	+3%	+$74.1K	0.71%	53
2020 Q2	$2.56M	Sell	15,753 -256	-2%	-$45.9K	0.68%	61
2020 Q1	$2.77M	Sell	16,009 -1,181	-7%	-$235K	0.91%	44
2019 Q4	$3.45M	Sell	17,190 -468	-3%	-$96K	0.84%	52
2019 Q3	$3.73M	Sell	17,658 -782	-4%	-$163K	1%	46
2019 Q2	$3.58M	Sell	18,440 -1,812	-9%	-$334K	0.93%	47
2019 Q1	$3.33M	Sell	20,252 -5,720	-22%	-$1.01M	0.91%	44
2018 Q4	$5.01M	Buy	25,972 +3,782	+17%	+$698K	2.18%	8
2018 Q3	$3.78M	Sell	22,190 -6,825	-24%	-$1.15M	1.78%	9
2018 Q2	$3.92M	Buy	29,015 +2,350	+9%	+$384K	1.92%	9
2018 Q1	$4.31M	Sell	26,665 -2,550	-9%	-$406K	2.24%	8
2017 Q4	$4.27M	Sell	29,215 -2,950	-9%	-$420K	2.08%	12
2017 Q3	$4.36M	Sell	32,165 -3,925	-11%	-$496K	2.52%	8
2017 Q2	$4.52M	Sell	36,090 -2,275	-6%	-$272K	2.81%	7
2017 Q1	$4.56M	Buy	+38,365	New	+$4.61M	3.22%	4

Other funds holding CME

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Parkside Investments's CME Position: Q2 2026 in Review

Parkside Investments reduced its CME Group (CME) stake by 0.81% in Q2 2026, selling an estimated $12.4K and leaving 5,493 shares worth $1.21M. The position accounts for 0.13% of the portfolio, ranked #62.

Parkside Investments first reported a position in CME in Q1 2017 and has held it in 38 quarters since. The position peaked at $5.01M in Q4 2018. 497 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Parkside Investments held 5,493 shares of CME Group worth $1.21M as of Q2 2026.
Parkside Investments sold 45 CME Group shares in Q2 2026, an estimated $12.4K.
CME Group made up 0.13% of Parkside Investments's portfolio in Q2 2026, its #62 holding.
Parkside Investments first reported a position in CME Group in Q1 2017 and has held it in 38 quarters since.
Parkside Investments's CME Group position peaked at $5.01M in Q4 2018.
497 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Parkside Investments's 13F filing for Q2 2026, filed 13 Jul 2026.